RESULT OF THE BUY-BACK OFFER

Udgivet den 14-02-2017  |  kl. 09:00  |  

Nasdaq Copenhagen
Nikolaj Plads 6
DK-1067 Copenhagen K   

Frederikssund, 14 February 2017
ANNOUNCEMENT NO. 3/2017

 

 

RESULT OF THE BUY-BACK OFFER

On 27 January 2017, Cemat A/S announced an offer to the shareholders to buy back the Company's own shares at a fixed price of DKK 0,352 per share.

At the end of the offer period, the Company has received 294,313,765 acceptances from shareholders representing 54.1% of the shares in the Company.

At the Company's general meeting held on 24 October 2016, the Board of Directors was authorised to buy back up to 337,993,060 shares, equivalent to around 62% of the shares in the Company.

As the number of shares tendered to the Company represents fewer shares than provided for under the authorisation, the number of shares purchased will not be reduced.

Immediately following this announcement, the Company will convene an annual general meeting to be held on 8 March 2017 for the adoption, among other things, of a capital reduction equivalent to the acceptances received. If the capital reduction is adopted, and if no significant claims are filed by creditors against the Company in the subsequent 4-week period (statutory notice), the Company is expected to complete and apply for registration of the capital reduction with the Danish Business Authority after expiry of the 4-week period on 11 April 2017.

Completion and settlement of the buy-back offer is expected to take place after the 4-week period on 11 April 2017.

Cemat A/S

Jens Borelli-Kjær

Chairman of the Board of Directors

 

This announcement has been issued in Danish and English. In case of any inconsistencies, the Danish version will prevail.

Unsubscribe announcements: investor@cemat.dk.

Vedhæftede filer:

03-17 Result of share buy-back offer.pdf

Udgivet af: NPinvestordk

Seneste nyheder

17:51 Europa/lukning: Mulig våbenhvile løftede markeder men pressede våbenaktier
17:06 Onsdagens aktier: Zealand med største stigning i C25-indeksets historie
17:03 Zealand brager op mens milliarderne fosser ud af Novo-aktien
17:01 Onsdagens obligationer: Aftagende amerikansk inflation sendte renten ned
15:24 Medie: Putin vil formentlig trække fredsforhandlinger i langdrag
14:59 Zealand Pharma på vej mod den største endagsstigning for et C25-selskab
14:44 USA/åbning: Aftagende inflation sender aktierne i vejret
14:34 Skako FY: Venter fremgang i 2025 efter usikkert år med tilbagegang
14:03 Økonomer: Inflationen går den rigtige vej - men Federal Reserve kan ikke ånde lettet op
13:37 Amerikansk inflation går den rigtige vej: Aftager mere end ventet i februar
13:19 USA/tendens: Udsigt til pæne plusser men inflationstal lurer
12:52 Trump indstiller Michelle Bowman som næstformand for Federal Reserves styrelsesråd
12:30 Tidligere Mærsk-topchef overtager formandsposten i Lundbeckfonden
12:12 Europa/aktier: Mulig våbenhvile løfter markeder men sænker våbenaktier
11:52 Obligationer/middag: Renten kravler svagt op før vigtig inflationsrapport
11:42 Puma styrtdykker efter dyster prognose
11:37 Aktier/middag: Zealand brager i vejret på bekostning af Novo efter milliardaftale
10:56 DFDS: Både fragtmængder og passagertal faldt i februar
09:52 Novo-aktien halveret siden toppen: Farvel til 2300 mia. kr. i markedsværdi
09:30 Novo-aktien halveret siden toppen: Farvel til 2300 mia. kr. i markedsværdi